Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis
Evan Der, … , Thomas Tuschl, Chaim Putterman
Evan Der, … , Thomas Tuschl, Chaim Putterman
Published May 4, 2017
Citation Information: JCI Insight. 2017;2(9):e93009. https://doi.org/10.1172/jci.insight.93009.
View: Text | PDF
Research Article Nephrology

Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis

  • Text
  • PDF
Abstract

Lupus nephritis is a leading cause of mortality among systemic lupus erythematosus (SLE) patients, and its heterogeneous nature poses a significant challenge to the development of effective diagnostics and treatments. Single cell RNA sequencing (scRNA-seq) offers a potential solution to dissect the heterogeneity of the disease and enables the study of similar cell types distant from the site of renal injury to identify novel biomarkers. We applied scRNA-seq to human renal and skin biopsy tissues and demonstrated that scRNA-seq can be performed on samples obtained during routine care. Chronicity index, IgG deposition, and quantity of proteinuria correlated with a transcriptomic-based score composed of IFN-inducible genes in renal tubular cells. Furthermore, analysis of cumulative expression profiles of single cell keratinocytes dissociated from nonlesional, non–sun-exposed skin of patients with lupus nephritis also revealed upregulation of IFN-inducible genes compared with keratinocytes isolated from healthy controls. This indicates the possible use of scRNA-seq analysis of skin biopsies as a biomarker of renal disease. These data support the potential utility of scRNA-seq to provide new insights into the pathogenesis of lupus nephritis and pave the way for exploiting a readily accessible tissue to reflect injury in the kidney.

Authors

Evan Der, Saritha Ranabothu, Hemant Suryawanshi, Kemal M. Akat, Robert Clancy, Pavel Morozov, Manjunath Kustagi, Mareike Czuppa, Peter Izmirly, H. Michael Belmont, Tao Wang, Nicole Jordan, Nicole Bornkamp, Janet Nwaukoni, July Martinez, Beatrice Goilav, Jill P. Buyon, Thomas Tuschl, Chaim Putterman

×

Figure 2

Pearson’s correlation between the average kidney single cell expression and a bulk sequenced renal biopsy.

Options: View larger image (or click on image) Download as PowerPoint
Pearson’s correlation between the average kidney single cell expression ...
Kidney single cells (n = 361) were averaged into a single “reconstructed” biopsy and correlated with a conventionally sequenced biopsy. Each dot represents a gene. Cell lineage markers for endothelial cells (light green: SELE, PECAM1, FLT1, LYVE1, VWF, MCAM, FLK1, CDH5, ARHGDIB, A2M, PTPRB ), fibroblasts (dark green: MFAP4, MFAP5, COL3A1, COL1A2, PRG4, COL1A1, PLA2G2A, APOD), tubular cells (yellow: UMOD, SLC12A1, SPP1, CA12, ALDOB, CALB1, PDZK1IP1, NAT8, SLC22A6, SLC22A8, AQP1, SLC34A1, SLC12A3, SCNN1B, CLCN5, CLDN16, GPX3, DEFB1, KCNJ1, KNG, SCNN1A, SLC22A2, PAX8, SLC23A3, KCNJ15, MT1G, SLC12A6, BHMT, ALDOB, SLC13A1), and leukocytes (pink: CD14, LYZ, FCER1G, CD4, MS4A6A, PTPRC, ITGAX, MRC1, CD247, FCGR2A, LTB, MARCO, EMR1, IL10RA ) are highlighted.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts